GI
BSX icon

GAMMA Investing’s Boston Scientific BSX Stock Holding History

GAMMA Investing’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.41M Buy
32,958
+7,612
+30% +$413K 0.05% 300
2026
Q1 		$1.59M Sell
25,346
-5,487
-18% -$439K 0.07% 238
2025
Q4 		$2.94M Sell
30,833
-2,184
-7% -$214K 0.15% 103
2025
Q3 		$3.22M Buy
33,017
+3,531
+12% +$366K 0.18% 86
2025
Q2 		$3.17M Buy
29,486
+3,932
+15% +$398K 0.2% 75
2025
Q1 		$2.58M Buy
25,554
+3,745
+17% +$377K 0.19% 87
2024
Q4 		$1.95M Buy
21,809
+4,377
+25% +$385K 0.17% 105
2024
Q3 		$1.46M Buy
17,432
+4,972
+40% +$392K 0.14% 133
2024
Q2 		$960K Buy
12,460
+2,854
+30% +$209K 0.13% 138
2024
Q1 		$658K Buy
9,606
+2,144
+29% +$138K 0.13% 139
2023
Q4 		$472K Buy
+7,462
New +$398K 0.13% 136

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

GAMMA Investing's BSX Position: Q2 2026 in Review

GAMMA Investing increased its Boston Scientific (BSX) stake by 30% in Q2 2026, buying an estimated $413K and bringing the position to 32,958 shares worth $1.41M. The position accounts for 0.05% of the portfolio, ranked #300.

GAMMA Investing first reported a position in BSX in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.22M in Q3 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • GAMMA Investing held 32,958 shares of Boston Scientific worth $1.41M as of Q2 2026.
  • GAMMA Investing bought 7,612 Boston Scientific shares in Q2 2026, an estimated $413K.
  • Boston Scientific made up 0.05% of GAMMA Investing's portfolio in Q2 2026, its #300 holding.
  • GAMMA Investing first reported a position in Boston Scientific in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Boston Scientific position peaked at $3.22M in Q3 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.